Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 86

1.
2.

Gene Therapy Corrects Brain and Behavioral Pathologies in CLN6-Batten Disease.

Cain JT, Likhite S, White KA, Timm DJ, Davis SS, Johnson TB, Dennys-Rivers CN, Rinaldi F, Motti D, Corcoran S, Morales P, Pierson C, Hughes SM, Lee SY, Kaspar BK, Meyer K, Weimer JM.

Mol Ther. 2019 Jul 10. pii: S1525-0016(19)30311-9. doi: 10.1016/j.ymthe.2019.06.015. [Epub ahead of print]

3.

Can Anti-Metastatic Albumin-based Superoxide Dismutase Mimetic Serve as a "Moonshot" Drug for Treatment for Brain Tumors - From Medulloblastoma to Glioblastoma?

Hsia CJC, Messerli SM, Miskimins WK.

Cell Biochem Biophys. 2019 Jun;77(2):121-122. doi: 10.1007/s12013-019-00869-2. Epub 2019 May 15. No abstract available.

PMID:
31093886
4.

Exosomal Induction of Tumor Innervation.

Vermeer PD.

Cancer Res. 2019 Jul 15;79(14):3529-3535. doi: 10.1158/0008-5472.CAN-18-3995. Epub 2019 May 14. Review.

PMID:
31088834
5.

Transcription factor TAp73 and microRNA-449 complement each other to support multiciliogenesis.

Wildung M, Esser TU, Grausam KB, Wiedwald C, Volceanov-Hahn L, Riedel D, Beuermann S, Li L, Zylla J, Guenther AK, Wienken M, Ercetin E, Han Z, Bremmer F, Shomroni O, Andreas S, Zhao H, Lizé M.

Cell Death Differ. 2019 May 8. doi: 10.1038/s41418-019-0332-7. [Epub ahead of print]

PMID:
31068677
6.

Innervation of cervical carcinoma is mediated by cancer-derived exosomes.

Lucido CT, Wynja E, Madeo M, Williamson CS, Schwartz LE, Imblum BA, Drapkin R, Vermeer PD.

Gynecol Oncol. 2019 Jul;154(1):228-235. doi: 10.1016/j.ygyno.2019.04.651. Epub 2019 Apr 17.

7.

Use of Antimetastatic SOD3-Mimetic Albumin as a Primer in Triple Negative Breast Cancer.

Messerli SM, Schaefer AM, Zhuang Y, Soltys BJ, Keime N, Jin J, Ma L, Hsia CJC, Miskimins WK.

J Oncol. 2019 Feb 28;2019:3253696. doi: 10.1155/2019/3253696. eCollection 2019.

8.

Defects in efferent duct multiciliogenesis underlie male infertility in GEMC1-, MCIDAS- or CCNO-deficient mice.

Terré B, Lewis M, Gil-Gómez G, Han Z, Lu H, Aguilera M, Prats N, Roy S, Zhao H, Stracker TH.

Development. 2019 Apr 23;146(8). pii: dev162628. doi: 10.1242/dev.162628.

PMID:
30936178
9.

Tracking sex-dependent differences in a mouse model of CLN6-Batten disease.

Poppens MJ, Cain JT, Johnson TB, White KA, Davis SS, Laufmann R, Kloth AD, Weimer JM.

Orphanet J Rare Dis. 2019 Jan 21;14(1):19. doi: 10.1186/s13023-019-0994-8.

10.

Targeting the Wnt/β-catenin pathway in human osteosarcoma cells.

Fang F, VanCleave A, Helmuth R, Torres H, Rickel K, Wollenzien H, Sun H, Zeng E, Zhao J, Tao J.

Oncotarget. 2018 Dec 4;9(95):36780-36792. doi: 10.18632/oncotarget.26377. eCollection 2018 Dec 4.

11.

Propranolol Promotes Glucose Dependence and Synergizes with Dichloroacetate for Anti-Cancer Activity in HNSCC.

Lucido CT, Miskimins WK, Vermeer PD.

Cancers (Basel). 2018 Nov 30;10(12). pii: E476. doi: 10.3390/cancers10120476.

12.

Characterization of a recurrent missense mutation in the forkhead DNA-binding domain of FOXP1.

Johnson TB, Mechels K, Anderson RE, Cain JT, Sturdevant DA, Braddock S, Pinz H, Wilson MA, Landsverk M, Roux KJ, Weimer JM.

Sci Rep. 2018 Nov 1;8(1):16161. doi: 10.1038/s41598-018-34437-0.

13.

Generation of a CLTA reporter human induced pluripotent stem cell line, CRMi001-A-1, using the CRISPR/Cas9 system to monitor endogenous clathrin trafficking.

Anderson RH, Kerkvliet JG, Otta JJ, Ross AD, Leiferman PC, Hoppe AD, Francis KR.

Stem Cell Res. 2018 Dec;33:95-99. doi: 10.1016/j.scr.2018.10.001. Epub 2018 Oct 3.

14.

Cancer exosomes induce tumor innervation.

Madeo M, Colbert PL, Vermeer DW, Lucido CT, Cain JT, Vichaya EG, Grossberg AJ, Muirhead D, Rickel AP, Hong Z, Zhao J, Weimer JM, Spanos WC, Lee JH, Dantzer R, Vermeer PD.

Nat Commun. 2018 Oct 16;9(1):4284. doi: 10.1038/s41467-018-06640-0.

15.

β2-Adrenergic receptor modulates mitochondrial metabolism and disease progression in recurrent/metastatic HPV(+) HNSCC.

Lucido CT, Callejas-Valera JL, Colbert PL, Vermeer DW, Miskimins WK, Spanos WC, Vermeer PD.

Oncogenesis. 2018 Oct 8;7(10):81. doi: 10.1038/s41389-018-0090-2.

16.

Preliminary observations of mitochondrial dysfunction in Prader-Willi syndrome.

Butler MG, Hossain WA, Tessman R, Krishnamurthy PC.

Am J Med Genet A. 2018 Dec;176(12):2587-2594. doi: 10.1002/ajmg.a.40526. Epub 2018 Oct 5.

PMID:
30289596
17.

UBXN2A enhances CHIP-mediated proteasomal degradation of oncoprotein mortalin-2 in cancer cells.

Sane S, Hafner A, Srinivasan R, Masood D, Slunecka JL, Noldner CJ, Hanson AD, Kruisselbrink T, Wang X, Wang Y, Yin J, Rezvani K.

Mol Oncol. 2018 Oct;12(10):1753-1777. doi: 10.1002/1878-0261.12372. Epub 2018 Sep 3.

18.

Differentiating Antiproliferative and Chemopreventive Modes of Activity for Electron-Deficient Aryl Isothiocyanates against Human MCF-7 Cells.

Anderson RH, Lensing CJ, Forred BJ, Amolins MW, Aegerter CL, Vitiello PF, Mays JR.

ChemMedChem. 2018 Aug 20;13(16):1695-1710. doi: 10.1002/cmdc.201800348. Epub 2018 Jul 20.

19.

Mesoporous silicate nanoparticles/3D nanofibrous scaffold-mediated dual-drug delivery for bone tissue engineering.

Yao Q, Liu Y, Selvaratnam B, Koodali RT, Sun H.

J Control Release. 2018 Jun 10;279:69-78. doi: 10.1016/j.jconrel.2018.04.011. Epub 2018 Apr 9.

20.

Functionalization of PCL-3D Electrospun Nanofibrous Scaffolds for Improved BMP2-Induced Bone Formation.

Miszuk JM, Xu T, Yao Q, Fang F, Childs JD, Hong Z, Tao J, Fong H, Sun H.

Appl Mater Today. 2018 Mar;10:194-202. doi: 10.1016/j.apmt.2017.12.004. Epub 2017 Dec 14.

Supplemental Content

Loading ...
Support Center